AI moving into clinical workflows

The flashy version of healthcare AI was easy to spot. It wrote notes, answered questions, and promised to remake medicine from the outside. The version now moving deeper into hospitals is quieter. It sits inside the electronic patient record, listens during visits, turns speech and clicks into structured fields, and feeds those fields back into the systems that run care and research. That is the shift behind the latest industry discussion: AI is no longer just a tool beside the workflow. It is becoming part of the workflow itself. (pharmexec.com) That matters because structured data is the fuel healthcare has always lacked. Claims data arrives late. Manual coding flattens nuance. Retrospective chart review is expensive and incomplete. A system that captures symptoms, medications, timing, and context at the point of care can produce a denser stream of clinical signals than those older sources. That is why companies selling “boring” infrastructure are suddenly more interesting than companies selling magic. The promise is not that AI will replace clinicians. The promise is that it will make the record more legible to the rest of the healthcare machine. (pharmexec.com) Once that data starts flowing, though, a harder question appears. Who actually created each fact in the record? A physician may have spoken it. A patient may have implied it. A model may have inferred it. Another system may have normalized it, mapped it to a standard term, or dropped part of it on the way. By the time a safety team sees a neat table for signal detection, the mess may already be hidden. The dataset can look cleaner precisely because the transformations have been pushed upstream into software. That is why provenance is becoming the real story. (pharmexec.com) Healthcare already has a vocabulary for this problem. HL7’s FHIR framework includes provenance guidance so exchanged data can carry information about who authored it, what system handled it, and when it changed. ONC’s HTI-1 rule pushed the same logic into certified health IT by requiring much more disclosure around predictive decision support interventions. The rule expanded source attributes for predictive tools to 31 items and tied them to ongoing maintenance, risk management, and governance. The point was not paperwork. The point was to make it possible for hospitals and clinicians to judge whether a model is fair, appropriate, valid, effective, and safe. (fhir.hl7.org) That regulatory pressure is arriving just as the market is losing patience with loose claims. PharmExec cited an 84 percent drop in Series B healthcare AI financing from late 2021 to late 2024 and argued that most enterprise pilots failed not because models were impossible, but because they could not survive interoperability, governance, and workflow reality. The same piece warned that unvalidated ambient tools can become “zombie algorithms,” embedded in care delivery without clear accountability. Once software starts shaping the official record, that warning stops sounding abstract. (pharmexec.com) Federal regulators are moving in the same direction. In January 2025, the FDA issued draft guidance for AI-enabled medical devices that spans the full product life cycle and calls for documentation, transparency, bias management, and postmarket performance monitoring. In August 2025, the agency finalized guidance on predetermined change control plans, a mechanism for managing planned updates to AI-enabled device software after launch. Both documents treat change history and monitoring as core safety issues, not technical footnotes. (fda.gov) That is the concrete consequence of AI moving into clinical workflows. The useful systems will not be the ones that merely generate more data. They will be the ones that can show, field by field and step by step, where that data came from, what touched it, and why it should still be trusted when it lands on a pharmacovigilance team’s screen. Starting January 1, 2025, developers with health IT certified to ONC’s Decision Support Interventions criterion have had to maintain exactly that kind of source-attribute information. (healthit.gov)